Towards the evolution of Evidence-Based Medicine.

The introduction and evolution of evidence-based stroke medicine has realized major advances in our knowledge about stroke, methods of medical research, and patient outcomes that continue to complement traditional individual patient care. It is humbling to recall the state of knowledge and scientific endeavour of our forebears who were unaware of what we know now and yet pursued the highest standards for evaluating and delivering effective stroke care. The science of stroke medicine has evolved from pathophysiological theory to empirical testing. Progress has been steady, despite inevitable disappointments and cul-de-sacs, and has occasionally been punctuated by sensational breakthroughs, such as the advent of reperfusion therapies guided by imaging.

While for many fields of practice ‘what works’ thinking was a relatively new phenomenon back in 2000, the field of health and healthcare could already look back on over a quarter of a century of debate about the challenges of using evidence in service delivery and improvement (Davies and Nutley, 2000). Systematic study in healthcare had found large and unjustified variations in clinical practice (Wennberg et al, 2016), significant levels of inappropriate care (Brook, 1994) and evidence of over-medicalisation and treatment-induced ill health (Illich, 1974). Questions were being asked about both the effectiveness and the cost-effectiveness of care (Cochrane, 1972). The development of Evidence Based Medicine (EBM) was one major response to these concerns, a development that has an interesting and well-documented history (summarised in Box 4.1). This chapter considers the on-going development and influence of this dominant discourse relating to evidence use. It discusses: the evolution of EBM; the importance of the nature and quality of evidence within EBM; the structures and systems that have emerged for the production and synthesis of research; and the development of key approaches to encouraging and enabling evidence use in medicine specifically and in healthcare more broadly. While evidence in healthcare has come to mean so much more than just clinical evidence, EBM remains the normative model against which other applications of evidence are so often compared. The EBM approach and the evidence-based movement associated with it can be regarded as a disruptive technology – a new way of doing things that sought to overturn previous practices.

Evidence-based medicine (EBM) is emerging as a new paradigm for medical practice. Medical librarians are to understand the concept of EBM, and particularly, improve their skills to efficiently search and evaluate the clinical literature. It is described the definition and the evolution of EBM, and more specific, how to search and evaluate the literature, and finally the example of evidence-based services at the Eskind Biomedical Library, Vanderbilt Medical Center. The Eskind Biomedical Library provides high-level data and knowledge organization skills to optimize the clinical, research and educational initiatives. Collaborating with clinicians and researchers, highly trained information specialists embed best practices in the organizing, structuring the institution's knowledge. This article is aimed to seek ways to provide advanced library information services for clinicians and the other healthcare providers in conjunction with evidence-based medicine.

This essay reviews the historical circumstances surrounding the introduction and evolution of evidence-based medicine. Criticisms of the approach are also considered. Weaknesses of existing standards of clinical practice and efforts to bring more certainty to clinical decision making were the foundation for evidence-based medicine, which integrates epidemiology and medical research. Because of its utility in designing randomized clinical trials, assessing the quality of the literature, and applying medical research at the bedside, evidence-based medicine will continue to have a strong influence on everyday clinical practice.

Perspective: Cell therapy, SARS-CoV-2, COVID-19, and James Lind.

Advances in COVID-19 management strategies with evolution of evidence-based medicine in India and associated ethical issues

Invited editorial: A guide to caring for patients who identify as transgender and gender diverse in the emergency department: The evolution of evidence-based medicine.

With evolution of evidence-based medicine, risk prediction equations have been formulated and validated. Such risk engines and scoring systems are able to predict disease outcome and risks of possible complications with varying degrees of accuracy. From health policy makers point of view it helps in appropriate disbursement of available resources for greatest benefit of population at risk. Understandably, the accuracy of prediction of different risk engines and scoring systems are highly variable and has several limitations. Each risk engine or clinical scoring tool is derived from data obtained from a particular population and its results are not generalizable and hence its ability to predict risk/outcome in a different population with differences in ethnicity, ages, and differences in distribution of risk factors over time both within and between populations. These scoring systems and risk engines to begin with were available for manual calculations and references/use of formula and paper charts were essential. However, with evolution of information technology such calculations became easier to make with use of online web-based tools. In recent times with advancement of android technology, easy to download apps (applications) has helped further to have the benefits of these online risk engines and scoring systems at our finger tips.

The Evolution of Evidence-Based Medicine: When the Magic of the Randomized Clinical Trial Meets Real-World Data.

Sharing information and databases with medical/health organisations has resulted in one small information unit being able to provide a more comprehensive service than would otherwise have been possible. The Qualitative Service in Aberdeen, part of the Information Services Team at Grampian Health Board, performs literature searches using a wide range of databases, thus responding to the increasing demand on the information profession, brought about by the evolution of evidence-based medicine. This paper is intended to show how this service has attempted to meet the demand for more information while working with limited resources. It also reiterates the benefits of using the less well-known sources, in addition to those already established as the key sources, such as Medline and Embase.

In their discussion paper, Miles and Mezzich argue that evidence-based medicine (EBM) and patient-centered care have developed in parallel, but rarely have entered into exchange and dialogue. These authors emphasize the need for a rational form of integration to take part between EBM and patient-centered care. We agree wholeheartedly with the desirability of both dialogue and integration. The dialogue will be much less likely to be productive, however, when authors ignore or altogether misconstrue the evolution of evidence-based medicine and the recent work of EBM leaders. Statements claiming “a foundational irreconcilability between the fundamental principles of EBM and those of patient-centered care” are not likely to promote enthusiastic dialogue with the EBM community. In this commentary, we demonstrate that EBM has introduced and aggressively advocated for the integration of patient’s values and preferences in the process of clinical decision-making. Furthermore, EBM has highlighted the need for research into optimal ways of integrating patient values and preferences and, most recently, introduced and studied innovative ways of facilitating shared decision-making.

Prior to the evolution of evidence-based medicine, medical practice was largely based on personal experience and widely accepted, but unproven theories. This often resulted in negative patient outcomes, which led to an increasing awareness that a standardized method to guide clinical practice was needed. This led to the advent of the evidence-based model, which focuses on answering a clinical question. With the practice of evidence-based medicine also came the need to improve current processes in order to continually provide quality, patient-centered care, i.e., the model for improvement. While both evidence-based model and the model for improvement are often considered separately, they are arguably linked together. Once evidence-based knowledge is organized into a guideline, policy, or procedure, it must be implemented into practice. This is a very complex task and must take into account many factors that will guide success or failure. Some of these factors are the desire and capacity to change, a gap where implementing knowledge will lead to an improved outcome, as well as internal and external cultural influences. Using a quality improvement method, such as the model for improvement, will allow for small tests of change and adjustments that will lead to stabilization when new evidence is implemented. Sustaining change is the final step and will require transparent feedback and data as well as ongoing evaluation of new evidence to achieve the best possible outcome.

467 WHEN BANTING AND BEST startled the science world in 1922 with the discovery of insulin, a relatively acute fatal disease of young people was soon transformed into the quintessential chronic illness. Despite fabulous inquiry into the very essence of our biological being, prevention or complete cure has eluded medicine and the millions of Americans who contend with this disease daily. The investment in labor and dollars to cure diabetes has been anything but futile. Reading the code of the human genome will teach us of its inviolable strengths and secure means to correct its frailties. Whereas the cure has been a step ahead for so many years, advances in technology have made the prospect of living with diabetes ever better. Courageous and determined diabetic patients matched with supportive families and conscientious health care have applied the best in technology in a team approach to make independent and long life an achievable prospect for the newly diagnosed diabetic. Diabetes was among the first medical conditions for which lifelong therapy was proposed. This moved the treatment of diabetes from the hospital to the medical office to the home to the workplace with full knowledge that very day was a treatment day and not a time between medical interventions. In the last 20 years this has meant daily monitoring of glucose, frequent insulin dosing, and a keen interest in reducing the crises, complications, and medical interventions. The patients and their families have become increasingly sophisticated as personal managers of their condition. The responsibility of the patient has matured from compliance to cooperation to empowerment. Devices for home monitoring have granted latitude for personal management impossible in the past. The role of the medical care team has also changed. Medicine has had the traditional role of diagnosis to inform patients of their peril, treatment if such was available, and caring for patients in their times of need. However, medicine has been a profoundly intermittent part of patients’ lives. You either got well, succumbed to the malady, or received instructions to accommodate to whatever disability ensued. This pattern of prescription, follow-up during therapy, and then pro re nata was not only accepted but considered practical. Now we are increasingly challenged to provide health maintenance, disease prevention, and disease management. Disease management implies perpetual and dynamic intervention to keep the toll of a disease at a minimum, to anticipate crises, and to afford the patient maximum independence in a personal life away from hospital and clinic. The concept of disease management is a mainstay in the care of cancer, hypertension, heart failure, asthma, HIV, and certainly diabetes mellitus. The practice standards of disease management are strongly supported in evidence and are part of the evolution of evidence-based medicine. There are trends in technology beyond the immediate research in diabetes itself. The promising areas are in data capture, decision